drugset / Trial / NCT07137585
A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With Type 2 Diabetes Mellitus (T2DM) and Overweight or Obesity
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main purpose of this study is to assess the effect of RO7204239 on insulin sensitivity versus placebo in participants with T2DM and obesity or overweight.
Timeline
- Start
- 2025-09-30
- Primary completion
- 2026-09-14
- Completion
- 2027-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EMUGROBART | Monoclonal antibody | — | Subcutaneous |